东北制药
(000597)
| 流通市值：75.55亿 | | | 总市值：76.74亿 |
| 流通股本：14.07亿 | | | 总股本：14.29亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 5,077,551,429.32 | 4,892,107,187.47 | 5,818,314,220.89 | 5,651,183,181.94 |
| 应收票据及应收账款 | 2,631,650,665.6 | 2,801,476,279.53 | 2,611,330,450.77 | 2,397,220,604.74 |
| 其中：应收票据 | 524,745,290.13 | 531,049,967.79 | 593,928,203.4 | 583,583,587.31 |
| 应收账款 | 2,106,905,375.47 | 2,270,426,311.74 | 2,017,402,247.37 | 1,813,637,017.43 |
| 预付款项 | 91,066,557.23 | 51,244,978.86 | 110,445,664.99 | 150,056,969.66 |
| 其他应收款合计 | 286,850,290 | 238,693,407.81 | 251,507,845.38 | 191,253,188.85 |
| 存货 | 1,272,892,511.17 | 1,404,346,807.26 | 1,433,135,077.17 | 1,364,090,227.71 |
| 合同资产 | 8,049,808.29 | 6,799,785.52 | 6,939,972.8 | 7,092,367.46 |
| 其他流动资产 | 37,125,258.05 | 34,322,136.69 | 25,631,706.05 | 22,163,503.64 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,405,186,519.66 | 9,428,990,583.14 | 10,257,304,938.05 | 9,783,060,044 |
| 非流动资产: | | | | |
| 固定资产 | 3,857,919,427.85 | 3,977,320,947.64 | 4,090,522,110.2 | 4,224,397,871.43 |
| 在建工程 | 210,538,173.92 | 240,439,766.35 | 216,903,716.67 | 198,865,519.16 |
| 使用权资产 | 39,370,423.13 | 42,442,020.8 | 44,905,190.94 | 53,433,397.64 |
| 无形资产 | 661,224,207.78 | 662,259,692.39 | 668,858,927.1 | 681,773,700.33 |
| 开发支出 | 140,138,131.24 | 145,759,695.38 | 148,337,927.78 | 142,722,332.74 |
| 商誉 | 26,118,604.81 | 26,118,604.81 | 26,118,604.81 | 26,118,604.81 |
| 长期待摊费用 | 744,659.79 | 606,302.26 | 675,688.45 | 745,074.64 |
| 递延所得税资产 | 127,741,624.42 | 118,434,762.51 | 121,972,503.17 | 128,068,299.04 |
| 其他非流动资产 | 28,091,436.71 | 27,331,136.23 | 30,558,650.48 | 34,468,798.34 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,091,886,689.65 | 5,240,712,928.37 | 5,348,853,319.6 | 5,490,593,598.13 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 14,497,073,209.31 | 14,669,703,511.51 | 15,606,158,257.65 | 15,273,653,642.13 |
| 流动负债: | | | | |
| 短期借款 | 1,482,200,000 | 1,577,200,000 | 1,570,629,999.99 | 1,290,429,999.99 |
| 应付票据及应付账款 | 5,019,626,916.02 | 5,032,655,567.46 | 5,816,453,856.39 | 5,777,647,320.02 |
| 其中：应付票据 | 3,679,496,265.44 | 3,434,837,873.48 | 4,427,259,843.7 | 4,379,546,536.53 |
| 应付账款 | 1,340,130,650.58 | 1,597,817,693.98 | 1,389,194,012.69 | 1,398,100,783.49 |
| 合同负债 | 85,340,999.38 | 69,663,250.63 | 79,237,698.6 | 131,168,024.29 |
| 应付职工薪酬 | 2,035,150.81 | 4,214,306.73 | 2,385,929.43 | 53,553,942.12 |
| 应交税费 | 59,011,826.09 | 82,950,379.76 | 79,433,740.15 | 90,924,585.21 |
| 其他应付款合计 | 1,494,050,366.01 | 1,607,893,244.92 | 1,615,490,195.04 | 1,466,608,057.23 |
| 其中:应付利息 | 1,572,237.34 | 750,386 | - | - |
| 应付股利 | 1,597,979.18 | 1,597,979.18 | 1,597,979.18 | 1,597,979.18 |
| 一年内到期的非流动负债 | 641,729,690.41 | 643,931,645.22 | 743,606,520.22 | 746,721,625.2 |
| 其他流动负债 | 8,995,300.82 | 6,957,193.48 | 8,201,871.71 | 11,434,480.58 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 8,792,990,249.54 | 9,025,465,588.2 | 9,915,439,811.53 | 9,568,488,034.64 |
| 非流动负债: | | | | |
| 长期借款 | - | 78,400,000 | 78,400,000 | 150,000,000 |
| 租赁负债 | 17,598,917.91 | 19,291,597.26 | 21,742,770.68 | 31,287,024.21 |
| 递延收益 | 144,875,730.85 | 148,911,071.12 | 152,946,411.39 | 157,118,947.05 |
| 递延所得税负债 | 3,170,418.01 | 3,305,058.36 | 3,147,337.51 | 5,217,346.26 |
| 其他非流动负债 | 185,200,000 | 185,200,000 | 202,800,000 | 202,800,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 350,845,066.77 | 435,107,726.74 | 459,036,519.58 | 546,423,317.52 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 9,143,835,316.31 | 9,460,573,314.94 | 10,374,476,331.11 | 10,114,911,352.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,429,103,265 | 1,429,103,265 | 1,429,103,265 | 1,429,103,265 |
| 资本公积 | 2,495,269,947.39 | 2,493,981,247.38 | 2,480,888,739.87 | 2,467,796,232.36 |
| 减:库存股 | 20,329,260 | 110,717,740 | 110,717,740 | 110,717,740 |
| 其他综合收益 | 1,496,987.17 | 2,190,307.11 | 2,016,867.18 | 1,950,394.12 |
| 专项储备 | 6,442,400.43 | 6,435,101.26 | 6,455,322.5 | 6,455,322.5 |
| 盈余公积 | 180,321,681.95 | 180,321,681.95 | 180,321,681.95 | 180,321,681.95 |
| 未分配利润 | 1,078,418,846.18 | 1,027,259,787.73 | 1,070,994,474.82 | 1,013,360,613.77 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,170,723,868.12 | 5,028,573,650.43 | 5,059,062,611.32 | 4,988,269,769.7 |
| 少数股东权益 | 182,514,024.88 | 180,556,546.14 | 172,619,315.22 | 170,472,520.27 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,353,237,893 | 5,209,130,196.57 | 5,231,681,926.54 | 5,158,742,289.97 |
| 负债和股东权益合计 | 14,497,073,209.31 | 14,669,703,511.51 | 15,606,158,257.65 | 15,273,653,642.13 |
| 公告日期 | 2024-10-24 | 2024-08-28 | 2024-04-26 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |